Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108484499A reveals a green rhodium-catalyzed route for isoquinoline derivatives, offering supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel synthesis route for Alvimopan intermediates via CN102127005A. Offers high purity, chiral control, and cost-effective API manufacturing solutions.
Patent CN115160146B reveals a high-yield one-pot synthesis for 1,2-cyclohexanediamine from cyclohexene oxide, offering significant cost reduction and supply chain stability for global buyers.
Advanced synthesis of alpha-isopropyl-3,4-dimethoxyphenylacetonitrile via patent CN113444020B. High-yield route for Verapamil intermediates with reduced toxicity and cost.
Patent CN108484499A reveals green rhodium catalyzed synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with high purity and supply reliability.
Novel salt formation method ensures over 99 percent purity for Perampanel intermediate. Reduces impurities significantly for reliable pharmaceutical intermediate supply chains.
Patent CN103025696B details a novel synthesis avoiding cryogenic conditions. This report analyzes cost reduction and supply chain reliability for high-purity intermediates.
Patent CN101333165B reveals low-temperature synthesis achieving high purity. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104560905B reveals green enzymatic route for chiral sulfoxides. Enables cost reduction and sustainable supply chain for pharmaceutical intermediates manufacturing globally.
Novel condensing agent process for Zafirlukast reduces impurities and cost. Reliable supply chain for asthma medication intermediates with scalable production.
Novel mild temperature synthesis for 3-difluoromethyl-1-methyl-pyrazole derivatives ensures over 99 percent purity and scalable manufacturing for global supply chains.
Patent CN111620793B details a copper-catalyzed asymmetric trifluoromethyl cyanation method offering high enantioselectivity and mild conditions for reliable pharmaceutical intermediate manufacturing.
Patent CN1514836A reveals a novel one-pot method for oxabispiperidine besylates, eliminating anion exchange steps for cost-effective pharmaceutical intermediate manufacturing.
Novel CDC25B inhibitor synthesis via microwave or base catalysis. High yield, scalable process for anti-tumor drug development and reliable supply chain.
Patent CN102311381A details a high-purity Heck coupling method for Acrivastine precursors, offering superior selectivity and simplified purification for pharmaceutical manufacturing.
Patent CN102775384B details novel iminosugar synthesis offering high-purity glycosidase inhibitors with streamlined commercial scale-up potential for global supply chains.
Efficient synthesis of daclatasvir starting material via patent CN107814789B. Low-cost route ensures supply chain stability for global API manufacturers.
Patent CN104169256B reveals efficient Pd-catalyzed route for Etoricoxib intermediate, offering supply chain stability and cost reduction for pharmaceutical manufacturing.
Novel odorless synthesis of L-erythro-biopterin via long-chain thiols. Reduces cost and improves supply chain reliability for API manufacturing.
Patent CN103936727A details a novel purification method reducing alpha-impurities. This ensures supply chain reliability and cost efficiency for pharmaceutical intermediates.